China's Baosteel to issue up to 3b yuan of bonds amid virus outbreak
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BEIJING] Baoshan Iron & Steel, China's top listed steel producer, said on Tuesday it would issue bonds worth up to 3 billion yuan (S$598.6 million), partly to boost working capital amid the coronavirus outbreak.
The bonds, with maturity of three years, will be the first tranche of the company's 20 billion yuan issuance plan from 2020 approved by the securities regulator in October.
The funds raised will also be used to repay debt, the company, also known as Baosteel, said in a filing to the Shanghai Stock Exchange.
Beijing has beefed up financial support to prop up businesses, allowing debt financing and debt issuance by companies heavily affected by a fast-spreading coronavirus.
The coronavirus outbreak, which has killed more than 2,900 in China and has spread across the globe, pushed steel products stockpiles in the country to a record high and threatened steelmakers' cash liquidity.
The most actively traded construction steel rebar contract on the Shanghai Futures Exchange had dropped more than 5 per cent since Jan 20.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
An official from China Baowu Steel Group, the parent company of Baosteel, said last month the latter's orders in March fell by around 5 per cent. He also expected the whole group's first-quarter profit to reduce by 2 billion yuan to 3 billion yuan hit by the epidemic.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant